JRF108

N/A

Report date: 2025/08/27 15:13:32
NME

Base Information

Drug NameJRF108
Drug Alias NameJRF-108JRF108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExtracellular-signal-regulated kinase1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors
TargetsExtracellular-signal-regulated kinase 2Extracellular-signal-regulated kinase1
Therapy Area/IndicationsPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChengdu Jinrui Foundation Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A